Pfizer Inc. Recall: Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, package
Pfizer Inc. Recall: Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, package is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Pfizer Inc.; Product: Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tab
| Recalling firm | Pfizer Inc. |
|---|---|
| Product | Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tablets), Rx Only, Distributed by Wyeth Pharmaceuticals LLC A subsidiary of Pfizer In Philadelphia, PA 19101 Made in Ireland, NDC 00008-1123-12 |
| Reason for recall | Failed Dissolution Specifications |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide within the United States |
| Recall initiated | 20200527 |
| Recall number | D-1342-2020 |
| Category | drug |
| State | NY |
| Country | United States |
$29/mo
Try RecallGuard →